GlassScriptPhysician profile
Jayaram S Hariharan
NPI 1790004638
$858.88
in general payments reported to CMS, 2019-2025
15 companies · $78.71 in 2025
The $78.71 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.10 · 2021: $129 · 2022: $177 · 2023: $207 · 2024: $249 · 2025: $78.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $169.33 | 2021-2025 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $168.18 | 2023-2024 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $108.34 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $101.28 | 2021-2024 | Gardasil 9, Gardasil, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $46.84 | 2022-2024 | |
| Lilly USA, LLC | $45.65 | 2023-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $37.01 | 2024 | Wegovy |
| Otsuka America Pharmaceutical, INC. | $33.32 | 2023 | Nuedexta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.08 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.20 | 2022 | |
| Sunovion Pharmaceuticals INC. | $19.69 | 2022 | |
| Edwards Lifesciences Corporation | $19.54 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kowa Pharmaceuticals America, INC. | $18.27 | 2025 | Zoryve |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.43 | 2022 | |
| Currax Pharmaceuticals LLC | $15.72 | 2023 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayaram Hariharan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.